CSIMarket



Stryker Corp  (SYK)
Other Ticker:  
 
 

SYK's Free Cash Flow Growth by Quarter and Year

Stryker's Free Cash Flow results by quarter and year




SYK Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1,000.00 1,237.00 735.00
III Quarter September - 933.00 829.00 629.00
II Quarter June - 878.00 620.00 514.00
I Quarter March 203.00 452.00 591.00 313.00
FY   203.00 3,263.00 3,277.00 2,191.00



SYK Free Cash Flow first quarter 2022 Y/Y Growth Comment
Stryker Corp reported drop in Free Cash Flow in the first quarter 2022 by -55.09% to $ 203.00 millions, from the same quarter in 2021.
The fall in the first quarter 2022 Stryker Corp's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow growth of 6.03%.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 7 other companies have achieved higher Free Cash Flow growth. While Stryker Corp' s Free Cash Flow meltdown of -55.09% ranks overall at the positon no. 483 in the first quarter 2022.




SYK Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -19.16 % 68.3 % -29.73 %
III Quarter September - 12.55 % 31.8 % -50.36 %
II Quarter June - 41.61 % 20.62 % -20.8 %
I Quarter March -55.09 % -23.52 % 88.82 % 5.39 %
FY   - -0.43 % 49.57 % -32.77 %

Financial Statements
Stryker's first quarter 2022 Free Cash Flow $ 203.00 millions SYK's Income Statement
Stryker's first quarter 2021 Free Cash Flow $ 452.00 millions Quarterly SYK's Income Statement
New: More SYK's historic Free Cash Flow Growth >>


SYK Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 7.18 % 49.22 % 16.85 %
III Quarter September - 6.26 % 33.71 % 22.37 %
II Quarter June - 94.25 % 4.91 % 64.22 %
I Quarter March -79.7 % -63.46 % -19.59 % -70.08 %
FY (Year on Year)   - -0.43 % 49.57 % -32.77 %




Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #36
Overall #483

Free Cash Flow Y/Y Growth Statistics
High Average Low
159.37 % 6.03 % -62.24 %
(Dec 31 2016)   (Sep. 30, 2015)
Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #36
Overall #483
Free Cash Flow Y/Y Growth Statistics
High Average Low
159.37 % 6.03 % -62.24 %
(Dec 31 2016)   (Sep. 30, 2015)

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Stryker's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
759.49 % 44.93 % -100 %
(Dec 31 2017)   (Dec 31 2011)


SYK's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Stryker Corp disclosed fall in Free Cash Flow from the forth quarter by -79.7% to $ 203.00 millions, from $ 1,000.00 millions declared a quarter before.

This is not huge concern, as Stryker's Free Cash Flow frequently tend to dip in this quarter.

Within Medical Equipment & Supplies industry 26 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Stryker's Free Cash Flow growth quarter on quarter, overall rank is 1456.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #27
Healthcare Sector #121
Overall #1456
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #27
Healthcare Sector #121
Overall #1456
Free Cash Flow Q/Q Growth Statistics
High Average Low
759.49 % 44.93 % -100 %
(Dec 31 2017)   (Dec 31 2011)


SYK's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Stryker Corp realized fall in Free Cash Flow sequentially by -79.7% to $ 203.00 millions, from $ 1,000.00 millions declared a quarter before.

If you look into present slump in the quarter, you suppose to take into consideration, that usually I. Quarter Free Cash Flow appear to be sluggish relative to the forth quarter

Within Medical Equipment & Supplies industry 26 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Stryker's Free Cash Flow growth quarter on quarter, overall rank is 1456.


Stryker's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ 3,575.00 $ 3,788.00 $ 3,984.00 $ 3,819.00 $ 3,564.00
Y / Y Free Cash Flow Growth (TTM) 0.31 % 0.64 % 20.87 % 19.72 % 13.5 %
Year on Year Free Cash Flow Growth Overall Ranking # 387 # 460 # 218 # 1026 # 977
Seqeuential Free Cash Flow Change (TTM) -5.62 % -4.92 % 4.32 % 7.15 % -5.31 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 483 # 334 # 1190 # 1140 # 1679




Cumulative Free Cash Flow growth Comment
With the quarterly Free Cash Flow reported in the Mar 31 2022 period, Stryker's cumulative twelve months Free Cash Flow were $ 3,575 millions, company would post below average annual Free Cash Flow growth of -5.31% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Stryker's Free Cash Flow growth from the 1000% growth in Dec 31 2021.

Within the Healthcare sector 23 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 387, from total ranking in previous quarter at 460.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
159.37 %
6.03 %
-62.24 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 8
Healthcare Sector # 24
Overall # 387

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
421.73 %
28.43 %
-78.11 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 36
S&P 500 # 483
Cumulative Free Cash Flow growth Comment
With the quarterly Free Cash Flow reported in the Mar 31 2022 period, Stryker's cumulative twelve months Free Cash Flow were $ 3,575 millions, company would post below average annual Free Cash Flow growth of -78.11% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Stryker's Free Cash Flow growth from the 1000% growth in Dec 31 2021.

Within the Healthcare sector 23 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 387, from total ranking in previous quarter at 460.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
159.37 %
6.03 %
-62.24 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 8
Healthcare Sector # 24
Overall # 387

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
421.73 %
28.43 %
-78.11 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 36
S&P 500 # 483




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
SYK's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for SYK's Competitors
Free Cash Flow Growth for Stryker's Suppliers
Free Cash Flow Growth for SYK's Customers

You may also want to know
SYK's Annual Growth Rates SYK's Profitability Ratios SYK's Asset Turnover Ratio SYK's Dividend Growth
SYK's Roe SYK's Valuation Ratios SYK's Financial Strength Ratios SYK's Dividend Payout Ratio
SYK's Roa SYK's Inventory Turnover Ratio SYK's Growth Rates SYK's Dividend Comparisons



Companies with similar Free Cash Flow fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2022
Bristol myers Squibb Company-0.31%$ -0.314 millions
Bio techne Corp-2.32%$ -2.321 millions
Edwards Lifesciences Corporation-2.40%$ -2.396 millions
Chemed Corporation-5.27%$ -5.275 millions
Moderna Inc -7.00%$ -7.001 millions
Idexx Laboratories Inc-7.81%$ -7.809 millions
Abcellera Biologics Inc -8.51%$ -8.513 millions
Abiomed Inc.-8.68%$ -8.676 millions
Utah Medical Products Inc-8.80%$ -8.802 millions
Amedisys Inc-9.96%$ -9.964 millions
Sotera Health Company-11.03%$ -11.026 millions
Royalty Pharma Plc-12.51%$ -12.513 millions
Ironwood Pharmaceuticals inc -12.99%$ -12.986 millions
Quidel Corporation-14.43%$ -14.431 millions
Endo International Plc-17.44%$ -17.438 millions
Amneal Pharmaceuticals Inc -18.76%$ -18.757 millions
Fulgent Genetics Inc -19.20%$ -19.199 millions
Medpace Holdings Inc -19.30%$ -19.301 millions
Bruker Corporation-20.61%$ -20.612 millions
Abbott Laboratories-21.69%$ -21.691 millions
Lemaitre Vascular Inc-22.44%$ -22.440 millions
Zoetis Inc -22.75%$ -22.750 millions
Axon Enterprise inc -27.86%$ -27.856 millions
Gilead Sciences Inc -29.50%$ -29.502 millions
Hca Healthcare Inc -32.34%$ -32.344 millions
U S Physical Therapy Inc-34.09%$ -34.090 millions
Quest Diagnostics Inc-34.34%$ -34.337 millions
Integra Lifesciences Holdings Corp-35.81%$ -35.809 millions
Co diagnostics Inc -36.38%$ -36.383 millions
Rackspace Technology Inc -37.50%$ -37.500 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BCLI's Profile

Stock Price

BCLI's Financials

Business Description

Fundamentals

Charts & Quotes

BCLI's News

Suppliers

BCLI's Competitors

Customers & Markets

Economic Indicators

BCLI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071